![Ann-Sofie Sternås](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann-Sofie Sternås
Corporate Officer/Principal bei
Akinion Pharmaceuticals AB
Profil
Ann-Sofie Sternås is currently working as the Director of Intellectual Property at Akinion Pharmaceuticals AB. Previously, she held positions as the Director of Intellectual Property at Axelar AB, Principal at AstraZeneca AB, and Vice President of Intellectual Property Rights at ClanoTech AB.
Aktive Positionen von Ann-Sofie Sternås
| Unternehmen | Position | Beginn |
|---|---|---|
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ann-Sofie Sternås
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Corporate Officer/Principal | - |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Health Technology |
